MetaCap

Pelthos Therapeutics Statistics

NYSE: PTHSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

6.38-0.61 (-8.73%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Pelthos Therapeutics by the numbers

Pelthos Therapeutics has a market capitalization of $25.1 million based on 3.93M shares outstanding. With trailing EPS of $-23.86, Pelthos Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 61.4% below its 50-day average and 72.3% below its 200-day average.

Average daily trading volume is 54.38K shares, or about $346,932 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PTHS valuation vs. peer median

PTHS compared with the median of 8 peer companies
MetricPTHSPeer medianDifference
Market cap$25.08M$25.03M+0%
Avg. volume54.38K124.11K-56%

Peer median across 8 companies: INMB, SAEN, LONA, EXOZ, MGX, CVM, EVAX, KLRS.

Valuation

Market cap
$25.08M
Price / sales (latest FY)
1.49
EPS (TTM)
$-23.86

Price and trading

Previous close
6.99
Open
6.96
Day range
6.38 – 7.21
52-week range
6.02 – 31.62
52-week change
-74.88%
Beta
—
Volume
63.96K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
25.08M
Forward Pe
-0.70
Eps
-23.86
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
31.62
Week52 Low
6.02
Avg Volume
54,378.00
Shares Outstanding
3.93M
Ma50
16.52
Ma200
23.02
Earnings Date
Nov 12, 2026
Pct From52w High
-79.82%
Pct From52w Low
5.98%

Related